Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bischofberger

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Journal of Medical Primatology|September 23, 2003
Transient early post-inoculation anti-retroviral treatment facilitates controlled infection with sparing of CD4+ T cells in gut-associated lymphoid tissues in SIVmac239-infected rhesus macaques, but not resistance to rechallengeJ D Lifson, M Piatak, A N Cline, et al.
The Journal of Clinical Investigation|July 6, 2000
Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeysH S Fox, M R Weed, S Huitron-Resendiz, et al.
Journal of Medical Primatology|November 21, 2000
Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infectionC C Tsai, P Emau, J C Sun, et al.
Journal of Virology|January 22, 2000
Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaquesB Rosenwirth, P ten Haaft, W M Bogers, et al.
Virology|January 9, 2001
Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected Rhesus macaques after short-term antiretroviral treatmentM Spring, C Stahl-Hennig, N Stolte, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 24, 1998
Efficacy of the acyclic nucleoside phosphonates (S)-9-(3-fluoro-2-phosphonylmethoxypropyl)adenine (FPMPA) and 9-(2-phosphonylmethoxyethyl)adenine (PMEA) against feline immunodeficiency virusK Hartmann, M Kuffer, J Balzarini, et al.
Journal of Virology|September 11, 1999
Postinoculation PMPA treatment, but not preinoculation immunomodulatory therapy, protects against development of acute disease induced by the unique simian immunodeficiency virus SIVsmmPBjS Hodge, J de Rosayro, A Glenn, et al.
Journal of Medicinal Chemistry|June 19, 1998
N2- and C8-substituted oligodeoxynucleotides with enhanced thrombin inhibitory activity in vitro and in vivoG X He, S H Krawczyk, S Swaminathan, et al.
Antimicrobial Agents and Chemotherapy|April 2, 1999
9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPAK K Van Rompay, J M Cherrington, M L Marthas, et al.
Journal of Medicinal Chemistry|October 23, 1998
In vitro and in vivo activities of oligodeoxynucleotide-based thrombin inhibitors containing neutral formacetal linkagesG X He, J P Williams, M J Postich, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Journal of Medical Primatology|September 23, 2003
Transient early post-inoculation anti-retroviral treatment facilitates controlled infection with sparing of CD4+ T cells in gut-associated lymphoid tissues in SIVmac239-infected rhesus macaques, but not resistance to rechallengeJ D Lifson, M Piatak, A N Cline, et al.
The Journal of Clinical Investigation|July 6, 2000
Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeysH S Fox, M R Weed, S Huitron-Resendiz, et al.
Journal of Medical Primatology|November 21, 2000
Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infectionC C Tsai, P Emau, J C Sun, et al.
Journal of Virology|January 22, 2000
Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaquesB Rosenwirth, P ten Haaft, W M Bogers, et al.
Virology|January 9, 2001
Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected Rhesus macaques after short-term antiretroviral treatmentM Spring, C Stahl-Hennig, N Stolte, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 24, 1998
Efficacy of the acyclic nucleoside phosphonates (S)-9-(3-fluoro-2-phosphonylmethoxypropyl)adenine (FPMPA) and 9-(2-phosphonylmethoxyethyl)adenine (PMEA) against feline immunodeficiency virusK Hartmann, M Kuffer, J Balzarini, et al.
Journal of Virology|September 11, 1999
Postinoculation PMPA treatment, but not preinoculation immunomodulatory therapy, protects against development of acute disease induced by the unique simian immunodeficiency virus SIVsmmPBjS Hodge, J de Rosayro, A Glenn, et al.
Journal of Medicinal Chemistry|June 19, 1998
N2- and C8-substituted oligodeoxynucleotides with enhanced thrombin inhibitory activity in vitro and in vivoG X He, S H Krawczyk, S Swaminathan, et al.
Antimicrobial Agents and Chemotherapy|April 2, 1999
9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPAK K Van Rompay, J M Cherrington, M L Marthas, et al.
Journal of Medicinal Chemistry|October 23, 1998
In vitro and in vivo activities of oligodeoxynucleotide-based thrombin inhibitors containing neutral formacetal linkagesG X He, J P Williams, M J Postich, et al.
Pageof 6